Image Description (Oxycarbazepine Oral Suspension Figure 1)
Oxcarbazepine Suspension
Product Images NDC 62135-841
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 62135-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Oxycarbazepine Oral Suspension Figure 2)
Image Description (Oxycarbazepine Oral Suspension Figure 3)
Image Description (Oxycarbazepine Oral Suspension Figure 4)
Image Description (Oxycarbazepine Oral Suspension Graph 1)
This is a log-rank test result showing a significant difference between treatment groups with a p-value of 0.0001. The analysis seems to involve a comparison of time or survival outcomes for participants receiving oxcarbazepine treatment.*
Image Description (Oxycarbazepine Oral Suspension Graph 2)
Image Description (Oxycarbazepine Oral Suspension Graph 3)
Image Description (Oxycarbazepine Oral Suspension Graph 4)
This is not a useful description.*
Image Description (Oxycarbazepine Oral Suspension Label)
This is a description based on the text: The text mentions information about a medication named Oxcarbazepine in Oral Suspension form with NDC 62135-841-54. It also includes some numerical and alphanumeric codes, possibly related to product identification.*
Image Description (Oxycarbazepine Oral Suspension Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
